Asunto(s)
Anestesia de Conducción/efectos adversos , Enfermedades del Sistema Nervioso/etiología , Medición de Resultados Informados por el Paciente , Lista de Verificación , Ensayos Clínicos como Asunto , Revelación , Humanos , Enfermedades del Sistema Nervioso/epidemiología , Complicaciones PosoperatoriasRESUMEN
Volumetric laser endomicroscopy (VLE) uses optical coherence tomography (OCT) for real-time, microscopic cross-sectional imaging. A US-based multi-center registry was constructed to prospectively collect data on patients undergoing upper endoscopy during which a VLE scan was performed. The objective of this registry was to determine usage patterns of VLE in clinical practice and to estimate quantitative and qualitative performance metrics as they are applied to Barrett's esophagus (BE) management. All procedures utilized the NvisionVLE Imaging System (NinePoint Medical, Bedford, MA) which was used by investigators to identify the tissue types present, along with focal areas of concern. Following the VLE procedure, investigators were asked to answer six key questions regarding how VLE impacted each case. Statistical analyses including neoplasia diagnostic yield improvement using VLE was performed. One thousand patients were enrolled across 18 US trial sites from August 2014 through April 2016. In patients with previously diagnosed or suspected BE (894/1000), investigators used VLE and identified areas of concern not seen on white light endoscopy (WLE) in 59% of the procedures. VLE imaging also guided tissue acquisition and treatment in 71% and 54% of procedures, respectively. VLE as an adjunct modality improved the neoplasia diagnostic yield by 55% beyond the standard of care practice. In patients with no prior history of therapy, and without visual findings from other technologies, VLE-guided tissue acquisition increased neoplasia detection over random biopsies by 700%. Registry investigators reported that VLE improved the BE management process when used as an adjunct tissue acquisition and treatment guidance tool. The ability of VLE to image large segments of the esophagus with microscopic cross-sectional detail may provide additional benefits including higher yield biopsies and more efficient tissue acquisition. Clinicaltrials.gov NCT02215291.
Asunto(s)
Esófago de Barrett/diagnóstico por imagen , Pautas de la Práctica en Medicina/estadística & datos numéricos , Tomografía de Coherencia Óptica/métodos , Adulto , Anciano , Anciano de 80 o más Años , Esófago de Barrett/patología , Esófago de Barrett/terapia , Biopsia , Toma de Decisiones Clínicas , Sistemas de Computación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Sistema de Registros , Tomografía de Coherencia Óptica/estadística & datos numéricos , Estados UnidosRESUMEN
INTRODUCTION: Jaundice is a common initial presentation of malignant biliary stricture. In patients with life expectancies that are greater than 3 months, self-expanding metal stents (SEMS) offer a larger diameter stent with longer patency and fewer complications compared to plastic stents. There have been conflicting results in the published literature as to efficacy and safety between the various SEMS types and diameters. We compared stent coating (PCSEMS vs USEMS) and diameter on clinical outcomes regarding management of malignant biliary obstruction. METHODS: A retrospective cohort study was conducted using a database of consecutive patients who underwent an ERCP with biliary SEMS placement (only 8 and 10 mm) between 2009 and 2017. RESULTS: In total, 278 patients who had SEMS at ERCP for malignant biliary obstruction were included (213 PCSEMS vs 65 USEMS). The groups were demographically evenly matched. Clinical success rates and patency duration were not statistically significant between PCSEMS and USEMS (98.1% vs 95.5%, P = 0.36, and 302.5 vs 225.5 days, P = 0.72, respectively). Adverse event rates were similar between both PCSEMS and USEMS with regard to overall adverse events. Stent diameter did not have an impact on overall clinical success (98.9% vs 95.3%, P = 0.11) or patency duration (239 days vs 336 days, P = 0.51). CONCLUSIONS: Our comparison of PCSEMS versus USEMS and 8 mm versus 10 mm showed no difference in clinical efficacy or adverse events between the two SEMS coatings and diameter, illustrating that coating and size do not matter in regard to stent choice, despite prior suggestive data.
Asunto(s)
Colestasis/diagnóstico , Colestasis/cirugía , Stents Metálicos Autoexpandibles/tendencias , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Bases de Datos Factuales/tendencias , Femenino , Humanos , Masculino , Persona de Mediana Edad , Falla de Prótesis/tendencias , Estudios Retrospectivos , Stents Metálicos Autoexpandibles/normas , Resultado del TratamientoRESUMEN
Nondysplastic Barrett's esophagus has a risk of progression to esophageal adenocarcinoma as low as 0.18-0.3% per person per year, and low-grade dysplasia as low as 0.5%. While adherence to guidelines and selection of management options varies, little is known about what modifies patient decision-making. This study aims to evaluate and identify factors that influence patient perceptions of risk and decisions about management. An independently developed and piloted survey was administered to patients at an academic hospital. Risk perception and desire for therapy were assessed using a standard reference gamble paradigm, and responses were stratified based on patient and disease characteristics. Data were analyzed with Student's t and chi-squared tests. A total of 42 of 50 patients with Barrett's esophagus and no prior endoscopic therapy participated (84% response; 76% nondysplastic Barrett's esophagus, 22% low-grade dysplasia, 2% indeterminate for dysplasia; mean age 61 years, 29% female). On average, patients perceived their risk of developing esophageal adenocarcinoma in the next year, 10 years and lifetime as 6, 14, and 19%, respectively. Nearly half viewed their lifetime risk of developing esophageal adenocarcinoma to be the same or higher than diabetes, heart disease, or colon cancer. Although 92% of patients felt surveillance beneficial, only 54% believed endoscopic therapy to be effective in most or all cases. As many as 83% of patients were willing to undergo endoscopic therapy with a hypothetical success rate as low as 70%, and a majority (64%) accepted complication rates up to 30%. Compared to patients with low risk perception of developing esophageal adenocarcinoma, those with high risk perception more often believed their risk for developing esophageal adenocarcinoma was greater than diabetes (p = 0.04) or colon cancer (p = 0.002). Those with lifetime low risk perception were less likely to accept modest complication rates (<10%) of therapy (P < 0.05). Age, gender, degree of dysplasia, lifetime endoscopies and duration of symptoms had no impact on perceived effectiveness of surveillance or therapy, and did not correlate with desire for treatment at varying levels of risk and effectiveness. Patients with Barrett's esophagus overestimate their risk of developing esophageal adenocarcinoma and will accept low success rates and high risk of complications to undergo endoscopic therapy. Baseline risk perception correlates with the desire for endoscopic therapy.
Asunto(s)
Adenocarcinoma/psicología , Actitud Frente a la Salud , Esófago de Barrett/psicología , Neoplasias Esofágicas/psicología , Esofagoscopía/psicología , Aceptación de la Atención de Salud/psicología , Adenocarcinoma/etiología , Adulto , Anciano , Esófago de Barrett/complicaciones , Progresión de la Enfermedad , Neoplasias Esofágicas/etiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Percepción , Medición de Riesgo , Factores de Riesgo , Encuestas y CuestionariosRESUMEN
A new series of 1,3-biarylsulfanyl derivatives (homodibenzyl core motif) have been designed and synthesized as new estrogen receptor ligands by chopping benzothiophene core of raloxifene to engender seco-raloxifene scaffold. All the synthesized compounds were screened for anti-proliferative, anti-osteoporotic, and anti-implantation activity. Compounds (35, 36) having basic amino anti-estrogenic side chain were exhibiting potential anti-proliferative activity in MCF-7, MDA-MB-231 and ishikawa cell lines. Some of the synthesized compounds having homodibenzyl motif (5, 8, 10) have shown moderate anti-osteoporotic activity.
Asunto(s)
Antineoplásicos/síntesis química , Antineoplásicos/farmacología , Neoplasias de la Mama/tratamiento farmacológico , Diseño de Fármacos , Compuestos de Sulfhidrilo/farmacología , Antineoplásicos/química , Neoplasias de la Mama/patología , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ensayos de Selección de Medicamentos Antitumorales , Femenino , Células HEK293 , Humanos , Modelos Moleculares , Conformación Molecular , Estereoisomerismo , Relación Estructura-Actividad , Compuestos de Sulfhidrilo/síntesis química , Compuestos de Sulfhidrilo/químicaRESUMEN
We sought to establish if smokers on anti-tuberculosis treatment are more likely to have a prolonged period of infectivity, compared to non-smoking tuberculosis patients, in a low tuberculosis prevalence country. We conducted a cross-sectional, retrospective study in Ireland that recruited 53 microbiologically confirmed cases of pulmonary tuberculosis (PTB). The age-sex adjusted odds ratios (AOR) suggest that the infectivity status of PTB on treatment was four times more likely to be prolonged beyond 6-8 weeks, if the cases had a smoking history (AOR: 4.42; 95% CI: 1.23; 15.9). Smoking was associated with delayed sputum smear conversion in PTB patients on treatment.
Asunto(s)
Fumar/fisiopatología , Esputo/microbiología , Tuberculosis Pulmonar/fisiopatología , Adulto , Antituberculosos/uso terapéutico , Estudios Transversales , Femenino , Humanos , Masculino , Estudios Retrospectivos , Tuberculosis Pulmonar/tratamiento farmacológicoRESUMEN
SETTING: In Pakistan approximately 5.7 million people suffer from tuberculosis, with 260 000 new cases occurring every year. This study was conducted in an outpatient hospital setting in Karachi. OBJECTIVE: To explore the level of awareness about tuberculosis amongst patients and their families, and recommend strategies for increasing understanding of the disease. DESIGN: Descriptive cross-sectional survey based on a structured questionnaire using convenience sampling. RESULTS: Of the 203 patients interviewed, 131 were males. Nearly 82% knew that tuberculosis is contagious and 78% were aware that lungs are commonly affected. Almost half knew that it spreads by droplets and causes cough and that treatment is long and costly. With regard to commonly affected age and sex, however, respectively only 43% and 23% had the correct knowledge. Less than one third could identify appropriate risk factors and ways to cure and limit spread. Almost half considered tuberculosis to be a social stigma. Media emerged as the main source of information. Respondents with more than 12 years of formal education were more likely to have better knowledge. CONCLUSIONS: Further population-based studies are recommended. Misconceptions about tuberculosis need to be removed through focused health education messages. The importance of complete and appropriate treatment needs to be emphasised.
Asunto(s)
Conocimientos, Actitudes y Práctica en Salud , Tuberculosis Pulmonar , Adulto , Estudios Transversales , Femenino , Educación en Salud , Humanos , Masculino , Persona de Mediana Edad , Servicio Ambulatorio en Hospital , Pakistán , Factores de Riesgo , Tuberculosis Pulmonar/prevención & controlRESUMEN
Isatin (10 mM) inhibited the activity of rabbit brush border sucrase by 60% at pH 5.0 but it had no effect on enzyme activity around neutral pH. Isatin inhibition of sucrase was unaffected by Na+ ions but K+ and Cs+ ions reduced enzyme inhibition, partially. Kinetic analysis revealed that sucrase inhibition by isatin at acidic pH was non-competitive with Ki of the order 6.5-7.8 mM. Isatin together with 4 mM harmaline or iodoacetate (3 mM) or dithionitrobenzene (2 mM) yielded 80-85% inhibition of the enzyme. These observations suggest that inhibitory sites for isatin, harmaline and -SH group reacting agents are distinct in rabbit brush border sucrase.
Asunto(s)
Intestinos/enzimología , Isatina/metabolismo , Sacarasa/antagonistas & inhibidores , Animales , Concentración de Iones de Hidrógeno , Intestinos/ultraestructura , Microvellosidades/enzimología , ConejosRESUMEN
A double-blind study was carried out in 62 hospital out-patients suffering from mild to moderate depression to investigate the efficacy and tolerance of fluvoxamine given as a single daily dose or in divided doses. Patients were allocated at random to receive 100 mg fluvoxamine either as a single daytime dose, a single night-time dose or as 50 mg twice daily over a period of 6 weeks after a 1 week wash-out period on placebo. Patients were assessed using the Hamilton and Montgomery Asberg depression rating scales and the Clinical Global Impression scale before and during treatment. All three dosage regimens produced significant improvement and no significant difference was found in antidepressive effect between the groups. However, patients receiving a single night-time dose experienced fewer side-effects leading to drop-out before the end of the study than in the other two groups.
Asunto(s)
Antidepresivos/administración & dosificación , Depresión/tratamiento farmacológico , Oximas/administración & dosificación , Adulto , Anciano , Antidepresivos/uso terapéutico , Ensayos Clínicos como Asunto , Método Doble Ciego , Esquema de Medicación , Tolerancia a Medicamentos , Femenino , Fluvoxamina , Humanos , Masculino , Persona de Mediana Edad , Oximas/uso terapéutico , Distribución AleatoriaRESUMEN
In a multi-centre study, the antidepressant efficacy and incidence of on-therapy events of trazodone (100 to 400 mg daily) and mianserin (30 to 120 mg daily) was compared using a double-blind pre-determined randomized parallel group design in depressed patients unresponsive to placebo after a 7-day screening period. Of the 111 patients who entered the study, 27 patients were withdrawn or defaulted. The withdrawal rate was similar between the treatment groups. The results of depression rating scale assessments showed that trazodone and mianserin were similar to each other for efficacy in patients judged to be suffering from severe or mild/moderate depression whether of the endogenous or reactive type. For all on-therapy events, there were no major differences between the treatments, with drowsiness being the most frequently reported side-effect.
Asunto(s)
Trastorno Depresivo/tratamiento farmacológico , Dibenzazepinas/uso terapéutico , Mianserina/uso terapéutico , Piperazinas/uso terapéutico , Trazodona/uso terapéutico , Adulto , Anciano , Ensayos Clínicos como Asunto , Método Doble Ciego , Femenino , Humanos , Masculino , Mianserina/efectos adversos , Persona de Mediana Edad , Trazodona/efectos adversosRESUMEN
Relative synthesis of malic enzyme is stimulated 25-to 100-fold by feeding neonatal ducklings or by incubating embryonic chick hepatocytes in culture with triiodothyronine. Synthesis of the enzyme is almost completely blocked when fed birds are starved or when triiodothyronine-treated hepatocytes in culture are also treated with glucagon. Cytoplasmic poly(A)+ RNA was isolated from livers of intact ducklings or hepatocytes in culture treated as described above and translated in an mRNA-dependent rabbit reticulocyte lysate. The identity of malic enzyme synthesized in the cell-free system was confirmed by virtue of its antigenicity, subunit molecular weight, and proteolytic peptide pattern. Translatable levels of malic enzyme mRNA paralleled changes in relative synthesis of malic enzyme in vivo and in hepatocytes in culture. Translatable levels od albumin mRNA were either unaffected or changed in a direction opposite to that of malic enzyme mRNA. Thus, both nutritional and hormonal regulation of malic enzyme synthesis involves regulation of cytoplasmic translatable malic enzyme mRNA levels. The hepatocyte culture system is ideally suited for future studies on the regulation of malic enzyme mRNA synthesis and/or degradation by thyroid hormone and glucagon.
Asunto(s)
Albúminas/genética , Hígado/metabolismo , Malato Deshidrogenasa/genética , Biosíntesis de Proteínas , ARN Mensajero/genética , Animales , Células Cultivadas , Embrión de Pollo , Patos , Fenómenos Fisiológicos de la Nutrición , Poli A/genética , ARN/genética , Conejos , ReticulocitosRESUMEN
Mature female rats were given U11,555A and U11,100A on orally on Day 2 of pregnancy and the number of implantations counted on Day 9. Using doses which reduced the implantation number to approximately 40% that of the controls, it was shown that the reduced number was not due to an effect on egg transport or to a delay of implantation.
Asunto(s)
Anticonceptivos Sintéticos Poscoito/farmacología , Anticonceptivos Poscoito/farmacología , Implantación del Embrión/efectos de los fármacos , Indenos/farmacología , Nafoxidina/farmacología , Transporte del Óvulo/efectos de los fármacos , Pirrolidinas/farmacología , Animales , Femenino , Tamaño de los Órganos/efectos de los fármacos , Ratas , Útero/efectos de los fármacosRESUMEN
The conjugation of glycine to benzoates and the conjugation of L-glutamine to certain arylacetates are catalyzed by two different acyl-CoA:amino acid N-acyltransferases which can be purified separately from liver mitochondrial fractions of either rhesus monkey or man. In both species, one transferase is specific for glycine and the other for L-glutamine. The glycine enzyme utilizes either butyryl-CoA or benzoyl-CoA as acyl donors while the glutamine enzyme uses either phenylacetyl-CoA or indoleacetyl-CoA. Acyl-CoA substrates for one transferase do not serve as substrates for the other. Additional studies with the monkey liver enzymes revealed that acyl-CoA substrates for one transferase inhibit the other, that the apparent Km value is low (10(-6) to 10(-5) M range) for the preferred acyl-CoA substrate as compared to the amino acid acceptor (greater than 10(-2) M) and that both transferases have a molecular weight of approximately 24,000. Hippuric acid and either phenylacetylglutamine or indoleacetylglutamine were characterized as the products formed by the separate enzymes.